INTERCONTINENTAL HUB EVIDENCE GENERATION LEAD (RWE)

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Country Location:

ICH Countries (Brazil, Colombia, Mexico, Gulf, KSA, Turkye, Australia, New Zeland, Taiwas, Korea, Alliance countries)

Path, Level And Scale

R Path

Travel Requirements

YES

Reporting To

AVP, ICH Strategic Capabilities & Transformation

Direct Reports

None – operates through scientific influence and cross-affiliate coordination

Intercontinental Hub Overview

The Intercontinental Hub (ICH) is part of Lilly’s International Business Unit (IBU) and represents a cluster of emerging and high-potential geographies including geographies with full-scale affiliate operations, distribution & promotion markets and hybrid partnership structures. These markets have complex environments that require deep technical expertise, agility and ability to work across different environments simultaneously. These markets represent close to 100 million people and are critical for expanding patient access and accelerating revenue growth globally.

Role Summary

The ICH Evidence Generation Lead (RWE) is responsible for leading the Integrated Evidence Generation capability at ICH level — concentrating RWE, health outcomes research, IIR, and medical evidence governance functions that benefit from cross-affiliate coordination rather than per-country resources. Operating within Lilly’s VEO framework, this role drives sustained integration of RWE and health outcomes from early clinical development through commercialization. The role partners with Country Medical Directors, Country Medical Heads, and IBU VEO to define evidence priorities. The role reports to the AVP, ICH Strategic Capabilities & Transformation and is a key member of the ICX Office.‑‑

Basic Requirements

• Education – Bachelor’s, MSc, PhD, MD, or PharmD/MS degree with significant experience in creating, executing, and delivering outcomes strategies and research projects; advanced scientific degree strongly preferred
• 10+ years’ of commercial business experience across sales, marketing or medical within the pharma industry
• Substantial experience in designing innovative and/or applying advanced methods for RWE and observational/epidemiologic studies; technical capabilities across RWE, patient-focused outcomes, burden of disease, epidemiology, statistics, and/or health care policy
• Strong scientific communication skills; demonstrated ability to translate and disseminate complex scientific information clearly; cross-functional collaboration skills across Medical Affairs, Regulatory, Commercial, and Market Access; international or multi-country medical affairs experience required
• English – business level required; Spanish and/or additional regional language preferred
  
  
  

Key Responsibilities

Integrated Journey Architecture

• Bridge Commercial and Medical OCE into a single, integrated journey architecture across ICH affiliates — eliminating parallel tracks and ensuring a coherent HCP experience from brand, scientific, field medical, and outcomes touchpoints
• Oversee how affiliates connect the dots across the HCP journey, ensuring brand, scientific, field medical, and outcomes touchpoints are sequenced as one coherent experience
• Serve as the connective tissue between Country Medical Directors, Commercial leads, and global OCE governance — translating strategic direction into executable cross-functional plan
  
  
  

Deep Digital House Expansion into Medical Affairs

• Accelerate the expansion of the Deep Digital House blueprint into Medical Affairs across ICH affiliates, translating global frameworks into executable models adapted to affiliate archetypes and maturity levels
• Partner with Country Medical Directors and affiliate medical teams to embed digital-first engagement practices into Medical Affairs execution, field medical operations, and scientific communication channels
  
  
  

Digital Readiness Acceleration for Non-Priority Markets

• Build a Digital Readiness Acceleration Framework for ICH markets outside global prioritization cycles, giving non-priority affiliates a self-sufficient path to OCE capability that does not depend on centrally-funded programs
• Identify and sequence capability-building interventions for low-maturity affiliates; coordinate IBU coaching support and ambassador-model knowledge transfer
  
  
  

Unified Performance Standards & Governance

• Set the unified Digital & OCE performance standard across ICH: shared KPI definitions, hub-level benchmarking, and a single view of HCP engagement across Commercial and Medical
• Monitor performance across the full engagement funnel for both commercial and medical channels; use data to inform strategy and report outcomes to ICH and IBU leadership
• Ensure governance alignment across the integrated OCE model; participate in ambassador model cadence and contribute to quarterly ICH capability reviews
  
  
  

Success Measures

• Single integrated OCE model operating across ICH affiliates — no commercial/medical split
• Deep Digital House blueprint successfully expanded into Medical Affairs in at least a defined subset of ICH affiliates per cycle
• Digital Readiness Acceleration Framework deployed and operational for non-priority ICH markets
• Unified KPI definitions and hub-level benchmarking dashboard established and reported consistently
• Affiliates with low OCE maturity demonstrably accelerated through ICH support without dependence on centrally-funded cycles
  
  
  

Leadership Competencies

• Integrity & Courage: Upholds regulatory and scientific standards for digital content across commercial and medical domains.
• Systems Thinking: Designs integrated OCE models that anticipate downstream compliance, engagement, and market maturity risks across a heterogeneous affiliate landscape.
• Influence & Communication: Translates complex digital frameworks into clear, actionable plans for affiliate marketing and medical teams; bridges Global, IBU, and affiliate realities.
• Inclusive Leadership: Adapts digital strategy to diverse market archetypes; ensures non-priority markets are not left behind in capability development.
• Operational Excellence: Drives execution speed, KPI clarity, and channel performance without sacrificing compliance or scientific integrity.
  
  
  

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

#WeAreLilly